AxoGen Company Profile (NASDAQ:AXGN)

About AxoGen

Industry, Sector and Symbol:

Sector: Medical
Industry: Medical Appliances & Equipment
Sub-Industry: N/A
Exchange: NASDAQ
Symbol: AXGN
CUSIP:

Key Metrics:

Previous Close: $8.62
50 Day Moving Average: $8.77
200 Day Moving Average: $6.70
52-Week Range: $3.83 - $9.88
Trailing P/E Ratio: N/A
Foreward P/E Ratio: -58.87
P/E Growth: 0.00
Market Cap: $266.07M
Outstanding Shares: 30,132,000
Beta: 0.1

Profitability:

Net Margins: -37.90%
Return on Equity: -193.60%
Return on Assets: -36.35%

Debt:

Debt-to-Equity Ratio: 8.94%
Current Ratio: 7.59%
Quick Ratio: 6.37%

Additional Links:

Companies Related to AxoGen:

Consensus Ratings for AxoGen (NASDAQ:AXGN) (?)

Ratings Breakdown:	2 Buy Ratings
Consensus Rating:	Buy (Score: 3.00)
Consensus Price Target:	$9.00 (1.93% upside)

Analysts' Ratings History for AxoGen (NASDAQ:AXGN)

Show:

Date	Firm	Action	Rating	Price Target
8/4/2016	Wedbush	Reiterated Rating	Outperform	$9.00 -> $10.00
11/6/2015	JMP Securities	Boost Price Target	Market Outperform	$5.50 -> $8.00
4/1/2015	Ladenburg Thalmann	Downgrade	Buy -> Neutral	$5.50 -> $3.75
11/26/2014	Lake Street Capital	Initiated Coverage	Buy

(Data available from 9/28/2014 forward)

Earnings History for AxoGen (NASDAQ:AXGN)

Date	Quarter	Consensus Estimate	Actual EPS	Release Link	Conference Call
8/3/2016
8/3/2016	Q2	($0.12)	($0.09)	View	N/A
8/6/2015		($0.14)	($0.13)	View	N/A
5/5/2015		($0.17)	($0.16)	View	N/A
3/5/2015		($0.15)	($0.21)	View	N/A
11/13/2014		($0.20)	($0.19)	View	N/A
8/4/2014		($0.22)	($0.21)	View	N/A
4/30/2014		($0.23)	($0.24)	View	N/A
3/6/2014		($0.22)	($0.24)	View	N/A

(Data available from 1/1/2011 forward)

Earnings Estimates for AxoGen (NASDAQ:AXGN)

Current Year EPS Consensus Estimate: $-0.35 EPS
Next Year EPS Consensus Estimate: $-0.15 EPS

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2016	2	($0.13)	($0.13)	($0.13)
Q2 2016	2	($0.13)	($0.10)	($0.12)
Q3 2016	2	($0.09)	($0.06)	($0.08)
Q4 2016	2	($0.13)	($0.09)	($0.11)
Q1 2017	1	($0.08)	($0.08)	($0.08)
Q2 2017	1	($0.02)	($0.02)	($0.02)
Q3 2017	1	$0.01	$0.01	$0.01
Q4 2017	1	($0.02)	($0.02)	($0.02)

(Data provided by Zacks Investment Research)

Dividend History for AxoGen (NASDAQ:AXGN)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for AxoGen (NASDAQ:AXGN)

Insider Ownership Percentage: 9.33%
Institutional Ownership Percentage: 57.99%

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
8/9/2016	Joseph M Mandato	Director	Sell	149,618	$8.54	$1,277,737.72
8/8/2016	Joseph M Mandato	Director	Sell	107,450	$8.63	$927,293.50
7/21/2016	James E Flynn	Insider	Sell	102,136	$6.70	$684,311.20
7/18/2016	James E Flynn	Insider	Sell	279,303	$7.53	$2,103,151.59
9/18/2015	James E Flynn	Insider	Sell	345,000	$5.50	$1,897,500.00
6/3/2015	Joseph M Mandato	Director	Buy	6,500	$3.10	$20,150.00
6/2/2015	Lee Robert Johnston Jr	Insider	Buy	5,000	$3.06	$15,300.00
4/8/2015	James E Flynn	Insider	Sell	144,385	$3.25	$469,251.25
12/10/2014	Lee Robert Johnston Jr	CFO	Buy	10,000	$3.06	$30,600.00
8/12/2014	Mark Stephen Gold	Director	Buy	20,000	$2.29	$45,800.00
8/8/2014	Mark Stephen Gold	Director	Buy	11,000	$2.31	$25,410.00
6/6/2014	Lee Robert Johnston Jr	CFO	Buy	10,000	$2.58	$25,800.00
6/3/2014	Gregory Gene Freitag	CFO	Buy	5,200	$2.45	$12,740.00
6/3/2014	Karen L Zaderej	CEO	Buy	5,000	$2.43	$12,150.00
5/20/2014	Jill F Schiaparelli	SVP	Buy	2,000	$2.63	$5,260.00
5/12/2014	Karen L Zaderej	CEO	Buy	5,000	$2.70	$13,500.00
5/7/2014	Mark Stephen Gold	Director	Buy	1,977	$2.60	$5,140.20
3/13/2014	Karen L Zaderej	CEO	Buy	1,500	$3.49	$5,235.00
8/29/2013	Shawn F Mccarrey	SVP	Buy	25,000	$3.21	$80,250.00
8/24/2013	Shawn F Mccarrey	SVP	Buy	5,000	$3.00	$15,000.00
8/14/2013	Jill F Schiaparelli	SVP	Buy	5,000	$3.00	$15,000.00
8/14/2013	John Frederick Harper	Director	Buy	66,666	$3.00	$199,998.00
8/14/2013	Karen L Zaderej	CEO	Buy	8,334	$3.00	$25,002.00
12/4/2012	Jill F Schiaparelli	SVP	Buy	2,000	$2.55	$5,100.00
11/29/2012	Jill F Schiaparelli	SVP	Buy	1,000	$2.70	$2,700.00
11/15/2012	Jill F Schiaparelli	SVP	Buy	2,750	$2.56	$7,040.00
10/1/2012	John Frederick Harper	Director	Buy	86,557	$3.61	$312,470.77

(Data available from 1/1/2013 forward)

Latest Headlines for AxoGen (NASDAQ:AXGN)

Date	Headline
	Join AxoGen and clinical experts for a discussion of clinical data on peripheral nerve repair (NASDAQ:AXGN) www.publicnow.com - September 28 at 8:30 AM
	ETF’s with exposure to AxoGen, Inc. : September 27, 2016 (NASDAQ:AXGN) www.capitalcube.com - September 27 at 3:41 PM
	Shares Of AxoGen, Inc. (NASDAQ:AXGN) Expected To Hit $10 - Investor Newswire (NASDAQ:AXGN) www.investornewswire.com - September 24 at 3:36 PM
	Teva Presents Top-Line Data from Huntington Disease Study - Yahoo Finance (NASDAQ:AXGN) finance.yahoo.com - September 20 at 3:39 PM
	Stock Update: Estimates & Target in Focus for AxoGen, Inc. (NASDAQ:AXGN) - Frisco Fastball (NASDAQ:AXGN) friscofastball.com - September 20 at 3:39 PM
	AxoGen, Inc. Appoints Amy Wendell to Board of Directors - GlobeNewswire (press release) (NASDAQ:AXGN) globenewswire.com - September 20 at 3:39 PM
	AXOGEN, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits (NASDAQ:AXGN) biz.yahoo.com - September 19 at 4:39 PM
	AxoGen : Appoints Amy Wendell to Board of Directors (NASDAQ:AXGN) www.4-traders.com - September 19 at 8:28 AM
	AxoGen, Inc. Appoints Amy Wendell to Board of Directors (NASDAQ:AXGN) finance.yahoo.com - September 19 at 8:28 AM
	Can Shares Of AxoGen, Inc. (NASDAQ:AXGN) Hit $10 - Investor Newswire (NASDAQ:AXGN) www.investornewswire.com - September 16 at 3:41 PM
	AxoGen to Participate at 71st Annual American Society for Surgery of the Hand Meeting - GlobeNewswire (press release) (NASDAQ:AXGN) globenewswire.com - September 15 at 12:35 PM
	AxoGen to Participate at 71st Annual American Society for Surgery of the Hand Meeting (NASDAQ:AXGN) finance.yahoo.com - September 15 at 12:35 PM
	AxoGen, Inc. to Participate at the American Association of Oral and Maxillofacial Surgeons 98th Annual Meeting - GlobeNewswire (press release) (NASDAQ:AXGN) globenewswire.com - September 12 at 3:40 PM
	AxoGen, Inc. to Participate at the American Association of Oral and Maxillofacial Surgeons 98th Annual Meeting (NASDAQ:AXGN) finance.yahoo.com - September 12 at 8:29 AM
	Steering Attention Towards Earnings; Analysts Weigh in on AxoGen, Inc. (NASDAQ:AXGN) Stock - Frisco Fastball (NASDAQ:AXGN) friscofastball.com - September 10 at 8:27 AM
	Shares Higher in Today's Session: AxoGen, Inc. (NASDAQ:AXGN) - Post News (NASDAQ:AXGN) www.kentuckypostnews.com - September 8 at 3:39 PM
	Allergan Takes Over RetroSense; Boosts Eye Care Pipeline (NASDAQ:AXGN) finance.yahoo.com - September 7 at 11:53 AM
	Shares Holding Above Moving Averages: AxoGen, Inc. (NASDAQ:AXGN) - Post News (NASDAQ:AXGN) www.kentuckypostnews.com - August 30 at 9:44 AM
	ETF’s with exposure to AxoGen, Inc. : August 29, 2016 (NASDAQ:AXGN) www.capitalcube.com - August 29 at 4:16 PM
	Will AxoGen, Inc. (NASDAQ:AXGN) Hit $10 Price Target? - Investor Newswire (NASDAQ:AXGN) www.investornewswire.com - August 20 at 3:44 PM
	Stock Runners: AxoGen, Inc. (NASDAQ:AXGN), Sorrento Therapeutics, Inc. (NASDAQ ... (NASDAQ:AXGN) www.kcregister.com - August 16 at 12:21 PM
	AxoGen, Inc. :AXGN-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016 (NASDAQ:AXGN) www.capitalcube.com - August 12 at 3:52 PM
	AxoGen, Inc. to Present at Wedbush PacGrow Healthcare Conference 2016 - GlobeNewswire (press release) (NASDAQ:AXGN) www.globenewswire.com - August 11 at 3:46 PM
	AXOGEN, INC. Financials (NASDAQ:AXGN) finance.yahoo.com - August 11 at 3:46 PM
	AxoGen, Inc. to Present at Wedbush PacGrow Healthcare Conference 2016 (NASDAQ:AXGN) finance.yahoo.com - August 11 at 12:55 PM
	Strong Sell Calls For AxoGen, Inc. (NASDAQ:AXGN) At 0 - Investor Newswire (NASDAQ:AXGN) www.investornewswire.com - August 6 at 11:26 AM
	AxoGen's (AXGN) CEO Karen Zaderej on Q2 2016 Results - Earnings Call Transcript (NASDAQ:AXGN) seekingalpha.com - August 4 at 12:14 PM
	After-Hours Stock Movers 08/03: (SQ) (PODD) (JACK) Higher; (TDOC) (SGMO) (FRSH) Lower (more...) (NASDAQ:AXGN) www.streetinsider.com - August 3 at 9:22 PM
	AxoGen, Inc. Reports Financial Results for Second Quarter 2016 (NASDAQ:AXGN) www.nasdaq.com - August 3 at 9:22 PM
	AxoGen reports 2Q loss (NASDAQ:AXGN) sg.finance.yahoo.com - August 3 at 9:22 PM
	Q2 2016 AxoGen Inc Earnings Release - After Market Close (NASDAQ:AXGN) biz.yahoo.com - August 3 at 12:20 PM
	ETF’s with exposure to AxoGen, Inc. : July 29, 2016 (NASDAQ:AXGN) www.capitalcube.com - July 29 at 1:15 PM
	AxoGen, Inc. to Report Second Quarter Financial Results and Host Conference Call on Wednesday, August 3, 2016 (NASDAQ:AXGN) finance.yahoo.com - July 20 at 7:00 AM
	AxoGen : Added to Russell 2000® Index (NASDAQ:AXGN) www.4-traders.com - July 18 at 8:35 AM
	AXOGEN, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits (NASDAQ:AXGN) biz.yahoo.com - July 6 at 4:31 PM
	AxoGen, Inc. (NASDAQ:AXGN) Company Rating and Target Watch - Telanagana Press (NASDAQ:AXGN) telanaganapress.com - June 29 at 11:52 AM
	AxoGen, Inc. Added to Russell 2000® Index - GlobeNewswire (press release) (NASDAQ:AXGN) globenewswire.com - June 29 at 11:52 AM
	AxoGen, Inc. (NasdaqCM:AXGN) Fundamental Star Rating Report - CML News (NASDAQ:AXGN) news.cmlviz.com - June 29 at 11:52 AM
	AxoGen, Inc. Added to Russell 2000® Index (NASDAQ:AXGN) finance.yahoo.com - June 27 at 7:00 AM
	ETF’s with exposure to AxoGen, Inc. : June 21, 2016 (NASDAQ:AXGN) www.capitalcube.com - June 21 at 12:47 PM
	7:15 am AxoGen announces four presentations related to use of Avance Nerve Graft at the FESSH Congress being held June 22-25 (NASDAQ:AXGN) finance.yahoo.com - June 21 at 7:15 AM
	AxoGen, Inc.’s Avance® Nerve Graft Data to be Presented at 2016 Federation of European Societies for Surgery of the Hand International Congress (NASDAQ:AXGN) finance.yahoo.com - June 21 at 7:00 AM
	AxoGen to Present at JMP Securities Healthcare Conference 2016 (NASDAQ:AXGN) finance.yahoo.com - June 16 at 7:00 AM
	AXOGEN, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vote of Securi (NASDAQ:AXGN) biz.yahoo.com - May 31 at 4:41 PM
	AxoGen reports 1Q loss (NASDAQ:AXGN) sg.finance.yahoo.com - May 4 at 7:12 PM
	AxoGen, Inc. First Quarter Revenue Increases 64% Over Prior Year to $8.1 Million (NASDAQ:AXGN) www.publicnow.com - May 4 at 4:31 PM
	AXOGEN, INC. Files SEC form 10-Q, Quarterly Report (NASDAQ:AXGN) biz.yahoo.com - May 4 at 4:09 PM
	Q1 2016 AxoGen Inc Earnings Release - After Market Close (NASDAQ:AXGN) biz.yahoo.com - May 4 at 7:07 AM
	AxoGen (AXGN) Enters Overbought Territory (NASDAQ:AXGN) finance.yahoo.com - April 29 at 9:52 AM
	AxoGen, Inc. to Report First Quarter Results (NASDAQ:AXGN) www.publicnow.com - April 20 at 8:31 AM